Is Open Text a buy? (February, 2025)

Following the company’s most recent quarterly results, National Bank Financial analyst Richard Tse remains on the fence with Open Text (Open Text Stock Quote, Chart, News, Analysts, Financials NASDAQ:OTEX).

On February 6, OTEX reported its Q2, 2025 results. The company posted Adjusted EBITDA of $501-million on revenue of $1.36-billion, down 13.1% year-over-year.

“OpenText’s Q2 results demonstrate the strength of our operating model, delivering $501 million of adjusted EBITDA, and 37.6% adjusted EBITDA margin, and generating $307 million of Free Cash Flows (FCF). The Company’s top priorities remain total growth, competitive advantage, margin expansion and FCF, while producing upper quartile capital returns,” CEO Mark J. Barrenechea said.

Tse summarized the quarter.

​

“OpenText reported solid FQ2 (Dec.) results relative to expectations with meaningful outperformance on profitability,” he wrote. “On the positive front, Cloud revenue grew by 2.7% Y/Y (vs. our 1.7% forecast), building on FQ1’s 1.3% growth with an unchanged FY25 Cloud target that implies a growth ramp to ~4.9% in FH2’25 for OpenText to hit the midpoint of guidance. That said, OpenText revised down its FY25 revenue guidance by ~$130 mln care of continued product growth challenges particularly in ADM and ITOM ($70 mln), FX ($35 mln), and the discontinuation of a former agreement with a partner DXC ($25 mln). Additionally, while the Company’s Cloud revenue target was unchanged, its Cloud bookings growth target was revised down slightly. The offset, OpenText’s FCF outlook increased from efficiency gains. Bottom line, we continue to see a balanced risk-to-reward profile for OpenText.”

In a research update to clients February 7, Tse maintained his “Sector Perform” rating and price target of (US) $38.00 on OTEX, implying a return of 32.2% at the time of publication.

The analyst thinks the company will post Adjusted EBITDA of $1.77-billion on revenue of $5.20-billion in fiscal 2025. He expects those numbers will improve to Adjusted EBITDA of $1.92-billion on a topline of $5.33-billion in fiscal 2026.

Tagged with: otex
Nick Waddell

Cantech Letter founder and editor Nick Waddell has lived in five Canadian provinces and is proud of his country's often overlooked contributions to the world of science and technology. Waddell takes a regular shift on the Canadian media circuit, making appearances on CTV, CBC and BNN, and contributing to publications such as Canadian Business and Business Insider.

Recent Posts

Auxly Cannabis is a winner, this analyst says

Haywood Securities analyst Neal Gilmer raised his target for Auxly Cannabis Group (Auxly Cannabis Group Stock Quote, Chart, News, Analysts,… [Read More]

2 days ago

RBC raises price target on CGI Group to $115.00

RBC Dominion Securities analyst Paul Treiber raised his target for CGI (CGI Stock Quote, Chart, News, Analysts, Financials TSX:GIB.A) to… [Read More]

2 days ago

Why is inflation so bad in Atlantic Canada?

Inflation is running above 3% in eight Canadian provinces, with Atlantic Canada facing some of the strongest price pressures as… [Read More]

2 days ago

Analyst chops target on goeasy (TSX:GSY)

National Bank Financial analyst Jaeme Gloyn lowered his target for goeasy (goeasy Stock Quote, Chart, News, Analysts, Financials TSX:GSY) to… [Read More]

2 days ago

Gain Therapeutics: this analyst just chopped his target

Roth Capital Partners analyst Boobalan Pachaiyappan lowered his target on Gain Therapeutics (Gain Therapeutics Stock Quote, Chart, News, Analysts, Financials… [Read More]

3 days ago

WELLSTAR Technologies is off to a great start, this analyst says

WELLSTAR Technologies’ (WELLSTAR Technologies Corp. Stock Quote, Chart, News, Analysts, Financials TSXV:WSTR) first quarterly results as a public company exceeded… [Read More]

3 days ago